Opko Health Inc. (OPK) Stock Price

OPKStock

$1.49+4.96%52W

Market Cap$1.11B

P/E—

PEG Ratio93.65

Div yield—

Beta1.51

OPK Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)10.07%

Price vs S&P 500 (4W)-13.35%

PEG Ratio93.65

VGM Score59.74

Book Value / Share (Quarterly)$1.59

P/TBV (Annual)1.74x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)3.64%

Cash Flow / Share (Quarterly)$-0.18

Price vs S&P 500 (YTD)5.50%

Gross Margin (TTM)38.00%

Net Profit Margin (TTM)-23.93%

EPS (TTM)$-0.10

10-Day Avg Trading Volume2.37M

EPS Excl Extra (TTM)$-0.10

Revenue Growth (5Y)0.78%

EPS (Annual)$-0.30

ROI (Annual)-13.96%

Gross Margin (Annual)36.84%

Net Profit Margin (5Y Avg)-12.72%

Cash / Share (Quarterly)$0.40

Revenue Growth QoQ (YoY)-0.64%

ROA (Last FY)-11.68%

Revenue Growth TTM (YoY)-28.95%

EBITD / Share (TTM)$-0.08

ROE (5Y Avg)-9.40%

Operating Margin (TTM)-16.52%

Cash Flow / Share (Annual)$-0.25

P/B Ratio0.88x

P/B Ratio (Quarterly)0.96x

Net Income / Employee (Annual)$-99,200

EV / Revenue (TTM)2.30x

Net Interest Coverage (TTM)-5.85x

ROA (TTM)-3.83%

EPS Growth QoQ (YoY)-22.63%

EV / EBITDA (TTM)7.82x

EPS Incl Extra (Annual)$-0.30

Current Ratio (Annual)3.97x

Quick Ratio (Quarterly)2.85x

3-Month Avg Trading Volume3.21M

52-Week Price Return4.96%

Revenue / Employee (TTM)$206,608,700,000

Tangible BV / Share (Quarterly)$0.69

P/S Ratio (Annual)1.21x

Asset Turnover (Annual)0.43x

52-Week High$1.73

Operating Margin (5Y Avg)-9.74%

EPS Excl Extra (Annual)$-0.30

CapEx CAGR (5Y)-11.98%

Tangible BV CAGR (5Y)-1.70%

26-Week Price Return21.31%

Quick Ratio (Annual)3.43x

13-Week Price Return15.63%

Total Debt / Equity (Annual)0.28x

Current Ratio (Quarterly)3.35x

Enterprise Value$1.09B

Revenue / Share Growth (5Y)-4.17%

Asset Turnover (TTM)0.40x

Book Value / Share Growth (5Y)-9.31%

Revenue / Employee (Annual)$379,600

Inventory Turnover (Annual)8.92x

Pretax Margin (Annual)-21.35%

Cash / Share (Annual)$0.48

3-Month Return Std Dev84.74%

Gross Margin (5Y Avg)34.81%

Net Income / Employee (TTM)$-32,000

EBITDA Interim CAGR (5Y)11.35%

ROE (Last FY)-17.80%

Net Interest Coverage (Annual)-25.97x

EPS Basic Excl Extra (Annual)$-0.30

P/FCF (TTM)33.18x

Receivables Turnover (TTM)7.21x

Total Debt / Equity (Quarterly)0.30x

EPS Incl Extra (TTM)$-0.10

Receivables Turnover (Annual)5.19x

ROI (TTM)-4.58%

P/S Ratio (TTM)1.35x

Pretax Margin (5Y Avg)-13.74%

Revenue / Share (Annual)$1.15

Tangible BV / Share (Annual)$0.73

Free OCF CAGR (5Y)10.98%

Price vs S&P 500 (52W)-13.35%

EPS Growth TTM (YoY)39.22%

Year-to-Date Return17.46%

5-Day Price Return8.82%

EPS Normalized (Annual)$-0.30

ROA (5Y Avg)-6.47%

Net Profit Margin (Annual)-21.87%

Month-to-Date Return12.12%

Cash Flow / Share (TTM)$-0.14

EBITD / Share (Annual)$-0.17

Operating Margin (Annual)-18.18%

LT Debt / Equity (Annual)0.26x

ROI (5Y Avg)-7.40%

LT Debt / Equity (Quarterly)0.29x

EPS Basic Excl Extra (TTM)$-0.10

P/TBV (Quarterly)2.21x

P/B Ratio (Annual)0.76x

Inventory Turnover (TTM)5.45x

Pretax Margin (TTM)-24.69%

Book Value / Share (Annual)$1.67

Price vs S&P 500 (13W)12.83%

Beta1.51x

P/FCF (Annual)157.21x

Revenue / Share (TTM)$1.15

ROE (TTM)-5.88%

52-Week Low$0.98

vGradeB

gGradeC

mGradeB

vgmGradeC

OPK Earnings Surprise History

Q2 25-0.08est. -0.10

Q3 250.03est. -0.04

Q4 25-0.04est. -0.07

Q1 26-0.07est. -0.07

Q2 26-0.03est. -0.11

OPK Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.82

3.90

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
OPKOpko Health Inc.	B	C	B	$1.49
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Opko Health Inc.

OPKO Health is a diversified biotechnology company with pharmaceutical and diagnostics segments operating globally. Its diagnostics division, which generates the majority of revenue, operates clinical and genomics laboratories through BioReference and point-of-care services. The pharmaceutical segment focuses on research, development, and commercial operations across multiple countries.